Jafra Capital Management’s Merck MRK Stock Holding History

Jafra Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-45,666	Closed	-$2.56M	–	83
2016 Q4	$2.56M	Buy	+45,666	New	+$2.67M	2.16%	19

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jafra Capital Management's MRK Position: Q1 2017 in Review

Jafra Capital Management sold out of Merck (MRK) in Q1 2017, closing a stake of 45,666 shares — an estimated $2.56M sold.

Jafra Capital Management first reported a position in MRK in Q4 2016 and held it in 1 quarter. The position peaked at $2.56M in Q4 2016. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

Jafra Capital Management reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
Jafra Capital Management sold 45,666 Merck shares in Q1 2017, an estimated $2.56M.
Jafra Capital Management first reported a position in Merck in Q4 2016 and held it in 1 quarter.
Jafra Capital Management's Merck position peaked at $2.56M in Q4 2016.
1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Jafra Capital Management's 13F filing for Q1 2017, filed 15 May 2017.